Prostate cancer Board decisions

The Board has determined that the veteran's prostate cancer was not incurred in or aggravated by active service and may not be presumed to have been incurred due to exposure to herbicides. The claim for service connection is therefore denied.

The Board has denied the veteran's claim for service connection for prostate cancer, finding that there is no competent medical evidence linking the current condition to his active duty service.

The Board found that prostate cancer, which was first diagnosed in 1993, is not service-connected due to lack of evidence linking it to service or exposure to ionizing radiation. The claim was denied as the preponderance of evidence did not support a finding of direct service connection.

The Board has determined that the veteran's prostate cancer is not related to his military service, including exposure to herbicides like Agent Orange. The claim for service connection is denied.

The Board denied service connection for pes planus, a stomach disorder, and prostate cancer. The veteran's claim for pes planus was not supported by evidence of pre-existing condition or aggravation in service.

The veteran's prostate cancer is being remanded for further consideration due to the need to refer the case to the Under Secretary for Benefits, as it involves exposure to ionizing radiation. The claim will be reopened based on new evidence.

The Board denied service connection for prostate cancer, finding no evidence of exposure to Agent Orange or other herbicides in Vietnam. The VA examiner opined that the veteran's prostate cancer was more likely than not related to his painting duties involving paint and solvents in service, but this opinion is considered non-competent as a layperson cannot establish such a link.

The veteran's claim for an increased evaluation of tinnitus was denied as the maximum schedular rating is already assigned. The claim for compensation under 38 U.S.C.A. § 1151 for prostate cancer was also denied due to lack of evidence showing VA negligence or fault.

The Board denied the veteran's appeal, finding that his residuals of prostate cancer were properly rated at a 20 percent level following reduction from 100 percent.

The Board has determined that the veteran's claims for service connection for various conditions, including chloracne, peripheral neuropathy, porphyria cutanea tarda, skin cancer, soft tissue sarcoma, multiple myeloma, Hodgkin's Disease, non-Hodgkin's lymphoma, cancer of the sinuses, respiratory cancer, cancer of the mouth with blindness, and prostate cancer are not reopened due to lack of new and material evidence.

The veteran's claims for service connection are being remanded due to the need for additional development, including consideration of new medical records and a videoconference hearing.

The Board found that the evidence received since the June 1999 denial is not new and material, thus denying the request to reopen the claim for service connection for the cause of the veteran's death.

The Board has determined that the veteran's prostate cancer and skin cancer were not incurred or aggravated during military service, within a year thereafter, or as a result of exposure to ionizing radiation. As such, service connection for these conditions is denied.

The Board denied the veteran's claim for an increased rating for his service-connected residuals of a shell fragment wound to the right thigh and denied his claim for service connection for prostate cancer. The veteran's prostate cancer was not shown to be related to his military service.

The Board found no evidence of negligence or other fault on VA's part, and thus denied the veteran's claim for compensation under 38 U.S.C. § 1151.

The Board denied the appellant's claims for service connection for the cause of the veteran's death and for Dependents' Education Assistance pursuant to Title 38, United States Code, Chapter 35. The evidence did not establish a link between the veteran's fatal renal cell carcinoma or prostate cancer and his military service.

The Board finds that the veteran's prostate cancer is not related to his active duty service, including exposure to radiation. The claim for service connection is denied.

The Board has ordered additional development to address the reduction of the veteran's disability rating for prostate cancer and his claim for service connection for a depressive disorder as secondary to his service-connected prostate cancer and erectile dysfunction.

The veteran's service-connected prostate cancer residuals have been productive of daytime voiding intervals between one and two hours, awakening to void three to four times per night, and mild stress incontinence. The criteria for a higher initial rating are not met.

The veteran's appeal is being remanded for further development and readjudication due to the need for a VA examination.